Trending...
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
CHARLOTTE, N.C., Oct. 7, 2024 ~ Charlotte, N.C. - Duke Energy (NYSE: DUK) has announced its quarterly cash dividends for both its common stock and Series A preferred stock. The company's common stock will receive a dividend of $1.045 per share, payable on December 16, 2024 to shareholders of record as of November 15, 2024.
In addition, the Series A preferred stock will receive a quarterly cash dividend of $359.375 per share, equivalent to $0.359375 per depositary share. This dividend will also be paid on December 16, 2024 to shareholders of record as of November 15, 2024.
Duke Energy has a long history of paying dividends on its common stock for the past 98 consecutive years. The company is one of America's largest energy holding companies and serves over 8 million customers in North Carolina, South Carolina, Florida, Indiana, Ohio and Kentucky through its electric utilities. It also serves over 1.7 million customers in North Carolina, South Carolina, Tennessee, Ohio and Kentucky through its natural gas utilities.
More on ncarol.com
As part of its commitment to clean energy transition, Duke Energy is working towards net-zero methane emissions from its natural gas business by 2030 and net-zero carbon emissions from electricity generation by 2050. The company is investing in major upgrades to its electric grid and cleaner generation methods such as expanded energy storage, renewables, natural gas and nuclear.
For more information about Duke Energy's initiatives and progress towards clean energy transition, visit their website at duke-energy.com or the Duke Energy News Center. You can also follow them on X, LinkedIn, Instagram and Facebook for updates and visit illumination for stories about the people and innovations powering their energy transition.
Media Contact: Gillian Moore
24-Hour: 800-559-3853
Analysts Contact: Abby Motsinger
Office:704-382-7624
In addition, the Series A preferred stock will receive a quarterly cash dividend of $359.375 per share, equivalent to $0.359375 per depositary share. This dividend will also be paid on December 16, 2024 to shareholders of record as of November 15, 2024.
Duke Energy has a long history of paying dividends on its common stock for the past 98 consecutive years. The company is one of America's largest energy holding companies and serves over 8 million customers in North Carolina, South Carolina, Florida, Indiana, Ohio and Kentucky through its electric utilities. It also serves over 1.7 million customers in North Carolina, South Carolina, Tennessee, Ohio and Kentucky through its natural gas utilities.
More on ncarol.com
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
- Interview: Why I Sponsored Carson Ware - The Full Story
- March Is Skiing's Smartest Buying Window
As part of its commitment to clean energy transition, Duke Energy is working towards net-zero methane emissions from its natural gas business by 2030 and net-zero carbon emissions from electricity generation by 2050. The company is investing in major upgrades to its electric grid and cleaner generation methods such as expanded energy storage, renewables, natural gas and nuclear.
For more information about Duke Energy's initiatives and progress towards clean energy transition, visit their website at duke-energy.com or the Duke Energy News Center. You can also follow them on X, LinkedIn, Instagram and Facebook for updates and visit illumination for stories about the people and innovations powering their energy transition.
Media Contact: Gillian Moore
24-Hour: 800-559-3853
Analysts Contact: Abby Motsinger
Office:704-382-7624
Filed Under: Business
0 Comments
Latest on ncarol.com
- P-Wave Classics to publish Robert Bage's Hermsprong in three volumes, beginning 12 May
- Ease Auto Group Inc. & Ease Fleet Repair Service Celebrate Grand Opening Charlotte, North Carolina
- Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
- CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
- Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
- Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
- FPTower Inc. nonprofit launches coastal safety raffle fundraiser
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- STEM Agent Academy Mission 01: Reclaiming Children's Curiosity from the Digital Void
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract